Company profile: Mablink Bioscience
1.1 - Company Overview
Company description
- Provider of biotechnology focused on developing a new class of cancer drugs, Antibody Drug Conjugate (ADC).
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Mablink Bioscience
Altar
HQ: France
Website
- Description: Provider of biotechnology solutions in automated fluidics, developing and operating proprietary technologies that bring microbes to performance suitable for commercial use. Serves customers leveraging microorganisms to produce food, feed, flavors & fragrances, cosmetics, and fuels.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Altar company profile →
Life Biosciences
HQ: United States
Website
- Description: Provider of drug development aimed at promoting longevity and finding treatments for age-related diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Life Biosciences company profile →
Aethon
HQ: United States
Website
- Description: Provider of automated hospital delivery and asset management solutions, including TUG®, an automated robotic delivery system transporting scheduled and on-demand deliveries across ancillary, support and patient care units. Offers autonomous mobile robots for material handling in hospitals, manufacturing and hotels, with secured delivery, cart handling, and payloads up to 1,400 lb.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aethon company profile →
Indigo Biosciences
HQ: United States
Website
- Description: Provider of nuclear receptor-focused products and services addressing therapeutic drug targets, including cell-based luciferase reporter assay kits for GPCR and nuclear receptors, Live Cell Multiplex assays to quantify live cells alongside nuclear receptor assays, INDIGlo luciferase detection reagent, environmental testing bioassays, and an ortholog assay portfolio for cross-species receptor activity comparison aiding selection of animal models for drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Indigo Biosciences company profile →
Beacon Discovery
HQ: United States
Website
- Description: Provider of GPCR-focused drug discovery services from concept to clinic, including over 8,000 assays, target identification, hit finding, lead optimization, mechanistic studies, and preclinical safety and toxicity. Offerings include small molecule support, LeadHunter cell-based assays for GPCRs and orphan GPCRs, phenotypic drug discovery, in vitro safety assays and panels, and ADME assays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Beacon Discovery company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Mablink Bioscience
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Mablink Bioscience
2.2 - Growth funds investing in similar companies to Mablink Bioscience
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Mablink Bioscience
4.2 - Public trading comparable groups for Mablink Bioscience
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →